Calpains are ubiquitous, well-conserved family of calcium-dependent, cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large subunit possesses a cysteine protease domain, and both subunits possess calcium-binding domains. Calpains have been implicated in neurodegenerative processes, as their activation can be triggered by calcium influx and oxidative stress. The protein encoded by this gene is expressed predominantly in stomach and small intestine and may have specialized functions in the digestive tract. This gene is thought to be associated with gastric cancer. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].
Davis, Martin, Patel, Green, Rakha, Ellis, Storr: "Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer." in: BMC cancer, Vol. 14, pp. 995, (2015) (PubMed).
Storr, Pu, Davis, Lobo, Reece-Smith, Parsons, Madhusudan, Martin: "Expression of the calpain system is associated with poor clinical outcome in gastro-oesophageal adenocarcinomas." in: Journal of gastroenterology, Vol. 48, Issue 11, pp. 1213-21, (2013) (PubMed).
Chen, Nguyen, Shively: "Role of calpain-9 and PKC-delta in the apoptotic mechanism of lumen formation in CEACAM1 transfected breast epithelial cells." in: Experimental cell research, Vol. 316, Issue 4, pp. 638-48, (2010) (PubMed).
Hata, Abe, Suzuki, Kitamura, Toyama-Sorimachi, Abe, Sakimura, Sorimachi: "Calpain 8/nCL-2 and calpain 9/nCL-4 constitute an active protease complex, G-calpain, involved in gastric mucosal defense." in: PLoS genetics, Vol. 6, Issue 7, pp. e1001040, (2010) (PubMed).